Study details
Enrolling now
Pramipexole to Enhance Social Connections
University of California, San Diego
NCT IDNCT06269146ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
108
Study length
about 1.9 years
Ages
18–50
Locations
2 sites in CA, NY
What this study is about
This trial is testing if pramipexole, a medication, can improve social connectedness in adults experiencing anxiety or depression. Participants will take either a placebo pill or pramipexole for 687 days. It aims to understand how pramipexole affects brain function and behavior related to social reward processing.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo Pill
- 2.Take Pramipexole Pill
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
NERVOUS SYSTEM
Drug routes
oral
Body systems
Psychiatry / Mental Health